SMTL ID : 7qgi.1

Crystal structure of SARS-CoV-2 NSP14 in the absence of NSP10

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.65 Å

Oligo State

monomer

Ligands

3 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: H.253, C.257, H.260, C.275 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:H.253, A:C.257, A:H.260, A:C.275 ZN.2: 4 residues within 4Å: Chain A: C.448, C.473, C.480, H.483 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.448, A:C.473, A:C.480, A:H.483 ZN.3: 4 residues within 4Å: Chain A: C.203, C.206, C.222, H.225 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.203, A:C.206, A:C.222, A:H.225

2 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.4: 4 residues within 4Å: Chain A: H.78, S.174, D.175, P.293 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:S.174, A:D.175 Salt bridges: A:H.78 PO4.5: 5 residues within 4Å: Chain A: Y.442, S.444, S.446, H.482, E.486 7 PLIP interactions: 7 interactions with chain A Hydrogen bonds: A:Y.442, A:S.444, A:S.444, A:S.446, A:E.486 Water bridges: A:S.444 Salt bridges: A:H.482

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Imprachim, N. et al., Crystal structures and fragment screening of SARS-CoV-2 NSP14 reveal details of exoribonuclease activation and mRNA capping and provide starting points for antiviral drug development. Nucleic Acids Res. (2023)

Release Date

2022-01-26

Peptides

Proofreading exoribonuclease nsp14: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
D

Proofreading exoribonuclease nsp14

Related Entries With Identical Sequence